When we think partnerships, we think diverse, bold, and inspired. It's in those partnerships where we can find an innovative medicine that saves a life. Or the licensing deal that broadens access to a critical drug. Or the technology collaboration that brings an experimental medicine to clinical trials faster. Or, even a business process that improves the way we help our customers.
Our partnerships, while individualized in scope and breadth, all offer the possibility of a healthier world. Read about some of our partnerships
Recent Partnerships
- June 6, 2013
CytomX and Pfizer Collaborate to Develop and Commercialize Multiple ProbodyTM-Drug Conjugates in Oncology
- April 29, 2013
Merck and Pfizer Collaborate to Develop New Diabetes Drug
- April 3, 2013
BIND Therapeutics Announces Global Collaboration with Pfizer to Develop and Commercialize Multiple Accurins
- January 3, 2013
Repligen announces Licensing Agreement with Pfizer for Spinal Muscular Atrophy Program
- January 3, 2013
Philogen S.p.A., a privately held clinical-stage biopharmaceutical company, today announced that it has entered into a strategic worldwide license agreement with Pfizer for Dekavil, a novel investigational therapy for autoimmune diseases
- December 21, 2012
Halozyme Therapeutics And Pfizer Enter Into A Collaboration To Develop And Commercialize Subcutaneous Biologics Using Recombinant Human Hyaluronidase
- December 20, 2012
Humedica and Pfizer Form Strategic Alliance
- November 30, 2012
Pfizer Completes Sale of Nutrition Business to Nestlé
- November 28, 2012
Pfizer Acquires NextWave Pharmaceuticals, Inc.
- November 19, 2012
Cystic Fibrosis Foundation Therapeutics Announces $58 Million CF Drug Discovery Agreement with Pfizer
- September 12, 2012
Pfizer And Hisun Announce Launch Of Hisun-Pfizer Pharmaceuticals Co., Ltd.
- August 21, 2012
VLST Corporation Announces In-licensing Agreement with Pfizer for Anti-CD40 Monoclonal Antibody
- August 13, 2012
Pfizer And Astrazeneca Enter Into Agreement For Over-The-Counter Nexium
- August 9, 2012
Nodality Enters into a Multi-Year Strategic Collaboration with Pfizer in Autoimmune Disease
- July 11, 2012
Verastem Acquires Clinical-Stage FAK Inhibitor from Pfizer
- May 1, 2012
Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSOTM
- April 23, 2012
Quark Pharmaceuticals Announces Phase 2a Study of PF-04523655 (PF-655)
- March 12, 2012
Biocon And Pfizer Conclude Commercialization Agreement
- February 27, 2012
Pfizer Acquires Alacer Corp., a Leading Vitamin Supplements Company
- February 17, 2012
Pfizer And Hisun Announce Progress On Potential Joint Venture
- January 25, 2012
KineMed announced a non-exclusive research collaboration with Pfizer for the advancement of novel approaches towards metabolic disease, in particular Type II Diabetes.
- January 10, 2012
Ventana Medical Systems announced a collaboration with Pfizer on a companion diagnostic to identify lung cancer patients with ALK gene rearrangements.
- January 09, 2012
SFJ Pharma announced a collaborative development agreement with Pfizer Inc. to conduct a Phase 3 clinical trial in Asia of Pfizer's investigational agent axitinib for the adjuvant treatment of patients at high risk of recurrent renal cell carcinoma(RCC) following nephrectomy.
- January 05, 2012
Catalyst Biosciences, Inc. announced that Pfizer Inc. has initiated a Phase 1 clinical trial for PF-05280602, an investigational proprietary, engineered variant of recombinant human Factor VIIa developed by Catalyst Biosciences.
- December 25, 2011
CollPlant Holdings Ltd. announced that CollPlant Ltd has signed a development agreement with Pfizer Inc., for the co-development of a product targeting the orthopedic market.
- December 24, 2011
Karo Bio AB announced that it has entered into a research collaboration agreement with Pfizer to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
- December 20, 2011
Antares announced a licensing deal with Pfizer Consumer Healthcare.
- December 13, 2011
Progress of GlycoMimetics' Novel Compounds Highlighted
- December 01, 2011
Pfizer Completes Acquisition of Ferrosan Consumer Health's Business
- December, 2011
KineMed announces research collaboration with Pfizer
- December, 2011
KaroBio enteres collaboration with Pfizer
- November 9, 2011
Children's Hospital Boston and Pfizer
- October 28, 2011
Pfizer Completes Acquisition of Icagen
- October 14, 2011
Findings from DiaGenic, Pfizer R&D Collaboration
- October 12, 2011
deCODE Announces Agreement with Pfizer
- October 10, 2011
Exonhit enters into Research Agreement
- October 5, 2011
Lpath Granted Two Additional U.S. Patents
- October 5, 2011
Pfizer Announces Licensing Agreement With Puma Biotechnology, Inc.
- October 3, 2011
MEDIMMUNE IN-LICENSES CANCER IMMUNOTHERAPY
- September 29, 2011
Lpath Initiates Dosing of iSONEP
- September 28, 2011
International Structural Genomics Consortium Announces $48.9 MILLION in Additional Funding
- August 29, 2011
Jennewein Biotechnologie and Pfizer Nutrition Collaborate
- August 16, 2011
QIAGEN and Pfizer partner to develop companion diagnostic
- August 3, 2011
Biotica regains worldwide rights to its rapamycin analogue program
- July 7, 2011
Pfizer To Explore Strategic Alternatives For Its Animal Health
- July 5, 2011
A prototype handheld device that analyses DNA to predict
- July 5, 2011
Cell Signaling Technology, Inc.
- June 14, 2011
Lpath Granted 22nd Patent Related to Lipidomics-Based Drug Development
- June 14, 2011
pSivida Announces Phase I-II Clinical Study Evaluating Bioerodible
- June 9, 2011
Biotica regains worldwide rights to its rapamycin
- June 2, 2011
Clovis Oncology, Inc. Receives License for Worldwide Development
- May 10, 2011
Cellzome to Study Epigenetic Factors with Neusentis
- May 10, 2011
Foundation for the NIH Launches Trial
- May 9, 2011
Staphylococcus aureus Investigational Vaccine Elicits a Positive Immune Response in Phase 1 Study
- May 4, 2011
Oxford BioMedica Broadens 5T4 Antibody Collaboration With Pfizer
- April 20, 2011
Pfizer and Shanghai Pharmaceutical Sign Memorandum
- April 11, 2011
Pfizer to Sell Capsugel to KKR
- April 7, 2011
Zacharon Pharmaceuticals Announces Research and Development Collaboration with Pfizer
- April 4, 2011
Rigel Assumes Development Responsibility
- March 3, 2011
CHARLES RIVER ANNOUNCES AGREEMENT
